Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$422.72M
Net Profit Margin
-12.90%
TTM Avg
-139.82%
3Y Avg
-135.58%
5Y Avg
-114.97%
Market Cap
$424.10M
Net Profit Margin
-6.77%
TTM Avg
-13.38%
3Y Avg
-17.48%
5Y Avg
-11.79%
Market Cap
$419.87M
Net Profit Margin
-80.67%
TTM Avg
-1305.53%
3Y Avg
-747.23%
5Y Avg
-2664.22%
Market Cap
$426.51M
Net Profit Margin
-184.24%
TTM Avg
-97.14%
3Y Avg
-46011.59%
5Y Avg
-30736.66%
Market Cap
$418.95M
Net Profit Margin
-157.32%
TTM Avg
-564.37%
3Y Avg
-610.78%
5Y Avg
-554.09%
Market Cap
$416.27M
Net Profit Margin
-225.34%
TTM Avg
-272.94%
3Y Avg
12.89%
5Y Avg
-949.96%
Market Cap
$431.97M
Net Profit Margin
-19.34%
TTM Avg
-27.72%
3Y Avg
-52.31%
5Y Avg
-58.02%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | -12.90% | -139.82% | -135.58% | -114.97% |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | -6.77% | -13.38% | -17.48% | -11.79% |
| Prothena Corporation plc (PRTA)vs › | $419.87M | -80.67% | -1305.53% | -747.23% | -2664.22% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | -184.24% | -97.14% | -46011.59% | -30736.66% |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -157.32% | -564.37% | -610.78% | -554.09% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -225.34% | -272.94% | 12.89% | -949.96% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | -19.34% | -27.72% | -52.31% | -58.02% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-03-31 | 0.00% |
